Heart Failure, Precision Medicine, and Incremental Equity: The Case of Hereditary Amyloid Cardiomyopathy

Echols and Taylor discuss hereditary amyloid cardiomyopathy. Heart failure is a complex clinical syndrome associated with frequently debilitating and lethal outcomes. Continual advancement in understanding the varied etiologies and specific molecular and mechanical processes underlying heart failure...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA : the journal of the American Medical Association 2022-04, Vol.327 (14), p.1341-1343
Hauptverfasser: Echols, Melvin R, Taylor, Herman
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Echols and Taylor discuss hereditary amyloid cardiomyopathy. Heart failure is a complex clinical syndrome associated with frequently debilitating and lethal outcomes. Continual advancement in understanding the varied etiologies and specific molecular and mechanical processes underlying heart failure have led to lifesaving advances in the management of this disorder; however, the annual morbidity, mortality, and economic costs related to heart failure remain unacceptably high. Improved care options, including the precise targeting of specific physiological derangements that underlie heart failure pathology, offer hope for an improved outlook for patients.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2022.2360